全文获取类型
收费全文 | 5256篇 |
免费 | 227篇 |
国内免费 | 182篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 17篇 |
妇产科学 | 18篇 |
基础医学 | 199篇 |
口腔科学 | 5篇 |
临床医学 | 1271篇 |
内科学 | 726篇 |
皮肤病学 | 29篇 |
神经病学 | 46篇 |
特种医学 | 114篇 |
外科学 | 1397篇 |
综合类 | 944篇 |
预防医学 | 382篇 |
眼科学 | 1篇 |
药学 | 403篇 |
14篇 | |
中国医学 | 76篇 |
肿瘤学 | 18篇 |
出版年
2024年 | 7篇 |
2023年 | 48篇 |
2022年 | 127篇 |
2021年 | 146篇 |
2020年 | 173篇 |
2019年 | 125篇 |
2018年 | 110篇 |
2017年 | 133篇 |
2016年 | 140篇 |
2015年 | 191篇 |
2014年 | 431篇 |
2013年 | 432篇 |
2012年 | 451篇 |
2011年 | 445篇 |
2010年 | 297篇 |
2009年 | 280篇 |
2008年 | 265篇 |
2007年 | 250篇 |
2006年 | 210篇 |
2005年 | 228篇 |
2004年 | 179篇 |
2003年 | 150篇 |
2002年 | 126篇 |
2001年 | 108篇 |
2000年 | 73篇 |
1999年 | 64篇 |
1998年 | 62篇 |
1997年 | 48篇 |
1996年 | 29篇 |
1995年 | 54篇 |
1994年 | 41篇 |
1993年 | 24篇 |
1992年 | 15篇 |
1991年 | 16篇 |
1990年 | 22篇 |
1989年 | 17篇 |
1988年 | 13篇 |
1987年 | 20篇 |
1986年 | 15篇 |
1985年 | 23篇 |
1984年 | 30篇 |
1983年 | 22篇 |
1982年 | 3篇 |
1981年 | 4篇 |
1980年 | 4篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1976年 | 3篇 |
1975年 | 3篇 |
1973年 | 1篇 |
排序方式: 共有5665条查询结果,搜索用时 0 毫秒
31.
A bloodless technique of evaluating protein catabolic rate (PCR) and KT/V (K, clearance; T, dialysis time; V, urea distribution volume) in hemodialysis patients is presented based on serial measurement of urea in the dialysate effluent stream. PCR follows from equating urea generation and urea removal over a 7 day cycle, changes in body stores being comparatively negligible: PCR = 0.026 [U1 + U2 + U3]/BWdry + 0.17, where U1 is the amount of urea in mmol appearing in the dialysate for each session in the 7 day period. KT/V is obtained from the slope of the natural logarithm of spent dialysate urea concentration-time plot: KT/V = [- slope.T + 3.delta BW/BWdry]/[1 - 0.01786.T(hr], where delta BW = amount ultrafiltered in liters. The dialysate-based approach was validated and compared with conventional urea kinetic modeling (UKM) for 17 patients studied for three consecutive dialyses. The dialysate-based and UKM values of PCR agreed well when in vivo clearance values based on total dialysate collection were used for UKM. KT/V values agreed poorly on a session-by-session basis but were nearly equivalent when averaged for the three dialyses of the week. These findings lay the foundation for UKM automation with a urea sensor in the effluent dialysate stream. 相似文献
32.
M. Fischler Professor Dr. H. M. Emrich W. Kissling D. v. Zerssen H. Riedhammer H. H. Edel 《European archives of psychiatry and clinical neuroscience》1979,227(3):207-212
Summary Therapeutic trials with hemodialysis have been performed in three cases of chronic schizophrenia. The severely ill patients had been hospitalized for more than ten years and had not responded to different types of conventional somatic treatment. Psychopathology was evaluated by use of the IMPS, BPRS, and NOSIE scales. No improvement could be observed as a consequence of 12 (11 in one case) hemodialysis treatments. Rather, some deterioration occurred in two of the patients. This result is not in accord with the markedly positive findings of Wagemaker and Cade (1977). However, further studies appear necessary to render final conclusions.Supported by a Stipendium of the Fritz-Thyssen-Foundation, Cologne 相似文献
33.
血液透析治疗海洛因依赖80例分析 总被引:3,自引:1,他引:3
目的:总结、分析血液透析治疗海洛因依赖的效果及原理。方法:对80例海洛因依赖者进行血液透析治疗1周。1周内透析2~3次,每次4 h;同时辅以抗焦虑、抗抑郁剂治疗;用美沙酮治疗80例作为对照组。结果:血液透析组80例患者均脱毒成功,未出现明显的戒断症状,效果优于美沙酮组(P<0.01)。结论:血液透析可能是较好的脱毒方法,脱毒快,成功率高,副作用小。 相似文献
34.
Hemodialysis in elderly patients 总被引:1,自引:0,他引:1
Brown WW 《International urology and nephrology》2000,32(1):127-135
International Urology and Nephrology - 相似文献
35.
Lee SH Huang JW Hung KY Leu LJ Kan YT Yang CS Chung Wu D Huang CL Chen PY Chen JS Chen WY 《Artificial organs》2000,24(11):841-844
A multicenter collaborative study was performed to investigate the prevalence of abnormal blood contents of 6 trace metals, copper (Cu), zinc (Zn), aluminum (Al), lead (Pb), cadmium (Cd), and mercury (Hg), in hemodialysis (HD) patients and to analyze their relationship with the medications, such as CaCO3, Ca acetate, Al containing phosphate-binding agents, 1,25-dihydroxy vitD3, 1-hydroxy vitD3, and erythropoietin (EPO), as well as hematocrit level, by chi-square statistics. From 6 medical centers in Taiwan, we included 456 patients in maintenance HD for more than 4 months for this study, and they had continued the previously mentioned medications for at least 3 months. Blood samples were collected before initiating HD, and atomic absorption spectrophotometry was used to measure plasma levels of Cu, Zn, and Al as well as whole blood levels of Pb, Cd, and Hg. Three hundred seventy-five (78%) of the HD patients had low plasma Zn levels, that is, <800 microg/L, and the mean (+/-SD) concentration was 705.8 (+/-128.23) microg/L in all subjects. One hundred forty-one (31%) of the HD patients had high plasma Al, that is, >50 microg/L, and the mean (+/-SD) was 44.30 (+/-28.28) microg/L in all subjects. Three hundred thirty-three (73%) of the dialysis patients had high Cd levels, that is, >2.5 microg/L, and the mean (+/-SD) was 3.32 (+/-1.49) microg/L in all subjects. The majority of HD patients had normal blood levels of Cu, PB, and Hg. Only 21 (4. 6%), 5 (1.1%), and 3 (0.06%) patients had elevated blood levels of Cu, Pb, and Hg, respectively. Their mean (+/-SD) blood concentration of Cu, Pb, and Hg were 1,049.78 (+/-233.25) microg/L, 7.45 (+/-3.95) microg/dL, and 3.17 (+/-25.56) microg/L, respectively. Three patients had elevated plasma Hg concentrations, that is, 546, 12.6, and 24.0 microg/L, respectively. In the 152 normal healthy age and sex matched control group, the blood levels of Al, Cd, and Pb were all significantly lower than the HD patients. However, the levels of Cu and Zn were higher in the control group. The Hg level was not significantly different in both groups. There was no statistical difference between patients with normal and abnormal blood levels of trace metals in various medications except Al containing phosphate binder. The Al containing phosphate binder users had significantly higher plasma Al levels (54.71 +/- 26.70 versus 41.15 +/- 28.03 microg/L, p < 0.001) and hematocrit levels (29.61 +/- 4.61 versus 27. 81 +/- 3.91, p < 0.0005). There was no statistical correlation between erythropoietin (EPO) dose and hematocrit level in these patients. In conclusion, the blood level of trace metals of these HD patients except Al was not related to their medications. However, caution must be exercised in interpreting this result as dose and duration of medication; efficiency of HD and water treatment may play an important role. Otherwise, environmental factors, diet, and the aging process may contribute to the trace metal burden in uremia. Thus, Zn and Cu are abundant in seafood, and Cd is abundant in contaminated plants such as rice. 相似文献
36.
Agroyannis B Paraskevopoulos A Kopelias I Tzanatos H Kapetanaki A Tsomi A 《Artificial organs》2000,24(9):743-745
The purpose of this study was to determine the changes of calcium and potassium content in red blood cells (RBC) from uremic patients during a hemodialysis (HD) session. In 17 uremic patients on HD, the calcium and potassium content of RBC was determined in 3 blood samples collected at 0 min-HD (pre-HD), 45 min-HD, and 240 min-HD (end-HD) during a 4 h HD session. The calcium and potassium content of RBC also was determined in 20 normal subjects (controls). The mean values (+/-SD) of RBC calcium content in patients at 0 min-HD, 45 min-HD, and 240 min-HD were 1.95 +/- 0.34, 2.82 +/- 0.50, and 2. 05 +/- 0.4 microg/ml, respectively, and in controls 0.61 +/- 0.14 microg/ml. These values show that the RBC calcium in patients was generally significantly higher (p < 0.0001) in comparison to that of controls. The RBC calcium at 45 min-HD was significantly higher as compared to that at 0 min-HD and at 240 min-HD (p < 0.0001). The mean values (+/-SD) of RBCs' potassium in uremic patients at the previously mentioned measurements were 95.9 +/- 3.34, 92.5 +/- 4.32, and 93.85 +/- 3.89 mEq/L, respectively, and in controls 98.46 +/- 2. 30 mEq/L. These values show that RBC potassium of patients was generally significantly lower in comparison to controls (0 min-HD: p < 0.01, 45 min-HD and 240 min-HD: p < 0.001). Potassium decrease also was significantly lower at 240 min-HD (p < 0.01) and even lower at 45 min-HD (p < 0.001) compared to that at 0 min-HD. In conclusion, uremic patients during an HD session present a high calcium and a low potassium content of erythrocytes. These changes may prevent swelling of the cells (Gardos effect). 相似文献
37.
急慢性肾衰竭并高钾血症542例次抢救体会 总被引:1,自引:0,他引:1
目的分析急慢性肾衰竭并高钾血症的临床表现和抢救体会。方法回顾性分析5年来用血液透析等抢救一组肾衰竭并高钾血症病人186例,共并发高钾血症542次的临床过程。结果540例次的临床症状改善,血清钾浓度降至正常范围,心电图的高血钾图象消失,2病例抢救无效死亡。抢救成功率99.6%。结论血液透析疗法是治疗高钾血症最有效的方法,使用含钾3.0~3.5mmol/L浓度的碳酸氢盐透析液进行透析,对降低高钾血症效果确切,可靠安全。血液透析治疗早期,不应作单纯超滤脱水治疗。透析早期仍有因高钾而致心跳骤停等危险,应随时准备心脏复苏等抢救。 相似文献
38.
39.
血液透析间期急性左心功能衰竭112例临床分析 总被引:7,自引:0,他引:7
目的 探讨尿毒症患者在血液透析间期发生急性左心衰的原因和提高防治效果。方法 选择112例慢性肾功能衰竭尿毒症期维持性血液透析治疗间期发生急性左心衰的患者。对其临床表现和治疗情况进行回顾性分析。结果 全组病例都有急性左心衰的临床表现,出现急性肺水肿13例,心电图提示ST段下降、T波倒置78例,左心室扩大31例,发生高血压95例,比上次超滤脱水后的体重(或干体重)增加超过3kg 71例,血清肌酐950~1200μmol/L 69例,超过1200μmol/L 43例;经过紧急血液透析。结合强心、扩血管药物对症治疗.本组病例均抢救成功。结论 认识尿毒症血液透析间期急性左心衰常见的临床表现有利于及早对其诊断;采取紧急血液透析和超滤脱水是提高疗效的关键,应该注意单纯超虑脱水的时间和数量;充分透析和透析间期控制体重、血压稳定是预防急性左心衰的重要措施。 相似文献
40.
目的探讨维持血液透析患者应用不同分子量肝素抗凝血小板参数变化。方法测定26例应用普通肝素(UFH)及38例应用低分子量肝素(LMWH)抗凝的血液透析患者血小板数量(PLT)及血小板平均体积(MPV),并进行对比,分别与30例健康体检者PLT及MPV进行比较。测定并比较18例患者自UFH改为LMWH抗凝3个月PLT及MPV的变化。结果UFH组PLT及MPV低于对照组(P<0.01);LMWH组PLT及MPV低于对照组,差异有显著意义(P<0.05);在UFH组及LMWH组间,后者PLT及MPV高于前者,(P<0.05);自UFH改为LMWH抗凝后,PLT及MPV有升高,但差异无显著意义(P>0.05)。结论肝素抗凝可致PLT及MPV下降,UFH尤其显著;UFH抗凝致PLT及MPV下降后改用LMWH抗凝并不能使PLT及MPV有明显上升。 相似文献